Embolic Agents for Subdural Hematoma

AA
Overseen ByAlycia Abler Clinical Research Project Manager
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Sanford Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Single site, prospective, comparative effectiveness pilot trial comparing efficacy and safety outcomes of three embolic materials (particles, liquid embolics, and Wallaby Phenox coils) in MMA embolication for cSDH.

Who Is on the Research Team?

DS

Divyajot Sandhu, MD, MBBS

Principal Investigator

Sanford Health

Are You a Good Fit for This Trial?

Inclusion Criteria

I am 18 years old or older.
I am having MMAE to treat my chronic subdural hematoma.
I can give consent for myself or have someone legally do it for me.

Exclusion Criteria

I am not eligible for the MMAE procedure, as decided by my doctor.
Pregnancy or breastfeeding
I cannot have an angiography due to health reasons.
See 3 more

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: MMA EmbolizationExperimental Treatment3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Sanford Health

Lead Sponsor

Trials
53
Recruited
2,067,000+

phenox Inc.

Industry Sponsor

Trials
1
Recruited
340+